A key reason positions haven't been filled is that they require travel that ranges from 25% to 75% of the time.

The U.S. Food and Drug Administration's ("FDA") new advisory committee on digital health is set to examine its approach for evaluating and ...

In August, Trump said he wouldn't rule out taking away access to mifepristone, which was also mentioned by the policy ...

Responding to Law Enforcement and Safeguarding Your Interests - In this final installment of our series on government ...

A new study found that many people on Medicare with low to moderate incomes don't have enough money to pay for a hospital ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular", the "Company"), a biopharmaceutical company committed to improving vision in the real world through ...

"I am thrilled to further strengthen and enrich Ocular's senior leadership team with the appointment of Namrata as Chief ...

Harriett said he is telling clients who want to buy a particular drug plan that doesn’t pay him commission that ... them CMS canceled their certification – they can’t write business, they can’t be ...

Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.